Novanta Inc. $NOVT Shares Acquired by Sei Investments Co.

Sei Investments Co. boosted its holdings in Novanta Inc. (NASDAQ:NOVT) by 47.6% in the first quarter, HoldingsChannel reports. The firm owned 484,316 shares of the technology company’s stock after purchasing an additional 156,263 shares during the period. Sei Investments Co.’s holdings in Novanta were worth $57,203,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the business. Allspring Global Investments Holdings LLC increased its holdings in Novanta by 27.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,776,694 shares of the technology company’s stock worth $210,307,000 after purchasing an additional 377,232 shares during the last quarter. Conestoga Capital Advisors LLC boosted its stake in shares of Novanta by 3.4% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,458,259 shares of the technology company’s stock valued at $173,518,000 after buying an additional 47,540 shares during the last quarter. State Street Corp grew its position in shares of Novanta by 1.0% during the fourth quarter. State Street Corp now owns 1,319,474 shares of the technology company’s stock worth $157,004,000 after buying an additional 13,603 shares in the last quarter. Wasatch Advisors LP grew its position in shares of Novanta by 10.6% during the second quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company’s stock worth $141,827,000 after buying an additional 104,985 shares in the last quarter. Finally, Bamco Inc. NY increased its stake in shares of Novanta by 49.4% in the fourth quarter. Bamco Inc. NY now owns 936,962 shares of the technology company’s stock worth $111,489,000 after buying an additional 309,869 shares during the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Stock Down 1.2%

Novanta stock opened at $141.54 on Friday. The company has a 50-day simple moving average of $155.63 and a 200-day simple moving average of $140.10. The firm has a market capitalization of $5.34 billion, a P/E ratio of 102.57 and a beta of 1.67. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.69 and a current ratio of 3.56. Novanta Inc. has a one year low of $98.27 and a one year high of $171.85.

Novanta (NASDAQ:NOVT) last posted its earnings results on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.78 by $0.03. The firm had revenue of $257.71 million for the quarter, compared to analysts’ expectations of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $0.74 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, equities analysts expect that Novanta Inc. will post 3.59 earnings per share for the current year.

Insider Buying and Selling at Novanta

In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the company’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total value of $1,047,345.00. Following the completion of the sale, the chief executive officer directly owned 29,761 shares of the company’s stock, valued at approximately $4,795,389.93. This represents a 17.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

NOVT has been the topic of a number of research analyst reports. Wall Street Zen upgraded shares of Novanta from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research note on Wednesday, July 15th. Finally, Robert W. Baird set a $180.00 target price on shares of Novanta in a research note on Tuesday, June 9th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Novanta has a consensus rating of “Hold” and an average price target of $180.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.